Pyrrole derivatives as pharmaceutical agents

Details for Australian Patent Application No. 2005266890 (hide)

Owner Exelixis, Inc.

Inventors Forsyth, Timothy Patrick; Martin, Richard; Stevens, William C. Jr.; Canne Bannen, Lynne; Gu, Xiao-Hui; Murphy, Brett; Mann, Grace; Nyman, Michael Charles; Wang, Tie-Lin; Chen, Jeff; Mohan, Raju; Mann, Larry W.; Dalrymple, Lisa Esther; Wong, Yong; Mac, Morrison B.; Flatt, Brenton T.; Wu, Jason H.

Agent Davies Collison Cave

Pub. Number AU-B-2005266890

PCT Pub. Number WO2006/012642

Priority 60/592,439 30.07.04 US; 60/592,469 30.07.04 US

Filing date 30 July 2005

Wipo publication date 2 February 2006

Acceptance publication date 6 October 2011

International Classifications

C07D 207/325 (2006.01) Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom

A61K 31/40 (2006.01) - having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil

Event Publications

8 February 2007 PCT application entered the National Phase

  PCT publication WO2006/012642 Priority application(s): WO2006/012642

27 September 2007 Amendment Made

  The nature of the amendment is: Amend the name of the co-inventor to read Gu, Xiao-Hui

6 October 2011 Application Accepted

  Published as AU-B-2005266890

2 February 2012 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2005266892-Use of IL-28 and IL-29 to treat cancer and autoimmune disorders

2005266887-Method of diagnosing, monitoring and treating pulmonary diseases